Alnylam Pharmaceuticals Aktie
262,40
EUR
+0,40
EUR
+0,15
%
309,00
USD
+2,40
USD
+0,78
%
Werbung
Alnylam Pharmaceuticals Aktie Analyse
| 20.08.08 | Alnylam Pharmaceuticals underperform | Leerink Swann LLC | |
| 03.03.08 | Alnylam Pharmaceuticals underperform | Needham & Company, LLC |
Werbung
Werbung